Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
03/2005
03/17/2005WO2005023831A1 Detection of cholesterol ozonation products
03/17/2005WO2005023318A1 Targeting of tumor vasculature using radiolabelled antibody l19 against fibronectin ed-b
03/17/2005WO2005023314A1 Compounds containing matrix metalloproteinase substrates and methods of their use
03/17/2005WO2005023303A1 Methods and compositions for treating herpes infections
03/17/2005WO2005023302A2 Anti-cd20 therapy of ocular disorders
03/17/2005WO2005023301A1 Remedy and detection drug for bile duct cancer
03/17/2005WO2005023300A2 Method for treating, preventing and/or diagnosing cancer, related to the use of mal2 polypeptide
03/17/2005WO2005023299A2 Therapeutic human anti-mhc class ii antibodies and their uses
03/17/2005WO2005023298A1 A method selecting an immunotherapeutic preparation
03/17/2005WO2005023205A2 Compositions and methods for yersinia pestis treatment
03/17/2005WO2005023201A2 Methods for treating rheumatoid arthritis
03/17/2005WO2005023193A2 Methods of treating endometriosis
03/17/2005WO2005023177A2 Human monoclonal antibodies against bacillusanthracis protective antigen
03/17/2005WO2005023083A2 Compositions and methods for the treatment of severe acute respiratory syndrome (sars)
03/17/2005WO2005016455A3 Antibodies against factor viii with modified glycosylation in the variable region
03/17/2005WO2005003175A3 Aglycosyl anti-cd154 (cd40 ligand) antibodies and uses thereof
03/17/2005WO2004113387A3 Tumour necrosis factor receptor molecules with reduced immunogenicity
03/17/2005WO2004094475A3 Tissue factor antibodies and uses thereof
03/17/2005WO2004089988A3 Inhibitors of integrin alpha5beta1 and their use for the control of tissue granulation
03/17/2005WO2004088326A3 Gastrin hormone immunoassays
03/17/2005WO2004067569A8 Internalising human binding molecules against cd72
03/17/2005WO2004060291A3 Uses of mammalian cytokine; related reagents
03/17/2005WO2004058822A3 Generation of immunoglobulin molecules with predetermined specificity
03/17/2005WO2004056862A3 Immunogenic compositions to the cck-b/gastrin receptor and methods for the treatment of tumors
03/17/2005WO2004050846A3 Wall teichoic acid as a target for anti-staphylococcal therapies and vaccines
03/17/2005WO2004039963A3 Antibodies specific for phosphorylated insulin receptor substrate-1/2 (ser 1101/ser1149) and uses thereof
03/17/2005WO2004038416A8 Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 6 (gpr6)
03/17/2005WO2004016750A3 FcϜRIIB-SPECIFIC ANTIBODIES AND METHODS OF USE THEREOF
03/17/2005WO2003104429B1 Genes overexpressed by ovarian cancer and their use in developing novel therapeutics
03/17/2005WO2003011898A3 Synthetic or natural peptides binding protein phosphatase 2a, identification method and uses
03/17/2005WO2002100343A3 N-terminally truncated galectin-3 and antibodies for treating cancer
03/17/2005US20050060763 Transgenic rodent model for use as tool in analysing the importance of light (L) chain expression for antibody development; immunotherapeutics
03/17/2005US20050060762 Plasmid construct comprising hybrid alpha -lactalbumin promoter for use as gene transfer and expression tool in genetic engineering; gene therapy and tissue engineering
03/17/2005US20050060123 Portable, self-contained data collection systems and methods
03/17/2005US20050059808 Mixture comprising type I transmembrane protein with immunoglobulin like extracellular domain for use as tool in identifying modulator which control development, differentiation and/or physiology of mammalian immune system
03/17/2005US20050059806 Expression vector comprising nucleotide sequences coding immunoglobulins for use in the treatment and prevention of asthma, food allergies, hypersensitivity and anaphylactic reactions; immunotherapy
03/17/2005US20050059803 Oligonucleotide probe for use in detection of phosphatidyl inositol 3 kinase expression; fungicides; antitumor agents
03/17/2005US20050059802 chimeric peptide of a peptide wherein the carboxyl terminus of the first portion (comprising a naturally-occurring internal peptide cleavage product) is linked to the amino terminus of the second portion (comprising a T helper cell epitope)
03/17/2005US20050059801 Transmembrane receptor/chemokine receptor for use in identifying modulators for treatment of glomerulonephritis, asthma, inflammatory bowel, transplant rejection and inflammation
03/17/2005US20050059622 Methods and compositions for modulating telomerase reverse transcriptase (TERT) expression
03/17/2005US20050059592 EphA2 and hyperproliferative cell disorders
03/17/2005US20050059591 Prevention and treatment of amyloidogenic disease
03/17/2005US20050059586 For increasing expression of human presenilin; for treatment of neurodegenerative diseases, Alzheimer's disease; drug screening
03/17/2005US20050059578 Compositions comprising phosphatidylethanolamine-binding peptides linked to anti-viral agents
03/17/2005US20050059143 Using formaldehyde and phenol mixture to sterilize and/or depyrogenate blood products; viricides; parasiticides; antiprotozoa agents
03/17/2005US20050059127 Method for recovering proteins from the interstitial fluid of plant tissues
03/17/2005US20050059121 Colony stimualting factor for use in animal vaccination and as nonspecific immunity stimulant; veterinary medicine
03/17/2005US20050059118 Hyaluronan receptor for endocytosis
03/17/2005US20050059117 Nucleotide sequences coding endothelial growth factor for use as tools in treatment and prevention of cell prolifreative disorders; antitumor agents
03/17/2005US20050059115 Using biglycan protein to diagnose, prevent and treatment of cell proliferative disorders
03/17/2005US20050059113 Antibodies to M-CSF
03/17/2005US20050059109 Methods and compositions for polypeptide engineering
03/17/2005US20050059108 Expression vector comprising nucleotide sequences coding neurotransmitter for use in prevention and treatment of obesity, anorexia, energy imbalance, diabetes, dyslipidemia, hypertension and/or insulin resistance
03/17/2005US20050059102 Monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative disorders; immunotherapy; immunodiagnostics
03/17/2005US20050059101 Modified bifunctional protein comprising two binding moieties specific to cancer associated antigens for use as tool in tissue targeted therapy of cell proliferative diseases
03/17/2005US20050059099 PSCA: prostate stem cell antigen and uses thereof
03/17/2005US20050059091 using a scanning probe microscope to determine and calculate the binding affinity between the first object and the first material from the force applied to remove the object from the first material.
03/17/2005US20050059087 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
03/17/2005US20050059082 Method for producing protein libraries and for selecting proteins from said libraries
03/17/2005US20050059081 Dipeptidyl peptidase IV (DPPIV); homology with family of prolyl oligopeptidases; drug screening for enzyme inhibitors for DPPIV which could treat reproductive, inflammatory and metabolic disorders; antibodies for therapeutic or diagnostic use; host cells
03/17/2005US20050059073 Expression vector comprising nucleotide sequences coding cell growth factors for use in treatment and prevention of nervous system disorders
03/17/2005US20050059061 Beta, beta-carotene 15,15'-enzymes, nucleic acid sequences coding therefor and their use
03/17/2005US20050059053 Generating plants comprising polypeptides with enhanced properties; directed evolution of proteins; bioreactor and heterologous gene expression
03/17/2005US20050059026 Using concentration of degraded or soluble matrix protein as diagnostic indicator of degree of apoptosis/necrosis in cell tissue
03/17/2005US20050059002 Novel serine protease
03/17/2005US20050058999 Gene involved in apoptosis regulation
03/17/2005US20050058994 Epitopes; immunoglobulins; hybridomas; diagnostic kits
03/17/2005US20050058993 Method and device for detecting feline immunodeficiency virus
03/17/2005US20050058992 Method and device for detecting feline immunodeficiency virus
03/17/2005US20050058984 Novel methods for displaying (poly)peptides/proteins on bacteriophage particles via disulfide bonds
03/17/2005US20050058983 Immunoglobulin which specifically binds to lymphadenopathy associated viral glycoprotein 120 for use as tool in prevention and treatment of viral infection; immunotherapy
03/17/2005US20050058660 Novel surface antigen
03/17/2005US20050058655 Vaccine and kit for viral disease in swine and diagnosis of diseases
03/17/2005US20050058652 Treatment of stomach cancer with steroid compounds and precipitation
03/17/2005US20050058649 Antibodies directed to phospholipase A2 and uses thereof
03/17/2005US20050058648 Antibodies against caspase-8, their preparation and use
03/17/2005US20050058647 Newly identified polypeptide and polynucleotides for diagnosis of new compounds
03/17/2005US20050058645 Antibodies that bind interleukin receptors for treatment of skin disorders, rhinitis, inflammatory bowel disease or breathing disorders
03/17/2005US20050058644 Compounds for treatment of cancer using lymphocytes, monoclonal antibodies and interferons
03/17/2005US20050058642 Antagonists and agonists of LDCAM and methods of use
03/17/2005US20050058641 Tolerance induction and maintenance in hematopoietic stem cell allografts
03/17/2005US20050058640 Antihemophilic factor; therapy for blood coagulation disorders; antibodies; culture product
03/17/2005US20050058639 Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof
03/17/2005US20050058638 Biosynthetic binding proteins for immuno-targeting
03/17/2005US20050058626 Vaccine against pathogens
03/17/2005US20050058624 Fusion proteins; adjust half-life; septic shock, diabetes, antiinflammatory agents
03/17/2005CA2540198A1 Tick engorgement factor proteins
03/17/2005CA2538319A1 Antibodies against interleukin-1 receptor and uses thereof
03/17/2005CA2538141A1 Therapeutic human anti-mhc class ii antibodies and their uses
03/17/2005CA2538012A1 Cyclic nucleotide-specific phosphodiesterases from leishmania and uses thereof
03/17/2005CA2537984A1 Detection of cholesterol ozonation products
03/17/2005CA2537881A1 Antibody-producing cell lines expressing activation-induced-cytidine-deaminase and a dominant negative allele of a mismatch repair gene
03/17/2005CA2537844A1 Treatment of neurodegenerative diseases
03/17/2005CA2537771A1 Compounds containing matrix metalloproteinase substrates and methods of their use
03/17/2005CA2537371A1 Antigenic peptides of rabies virus and uses thereof
03/17/2005CA2536256A1 Targeting of tumor vasculature using radiolabelled antibody l19 against fibronectin ed-b
03/17/2005CA2535895A1 Anti-cd20 therapy of ocular disorders
03/17/2005CA2534907A1 Homogeneous preparations of il-28 and il-29
03/17/2005CA2534886A1 A method selecting an immunotherapeutic preparation
03/17/2005CA2526398A1 Human monoclonal antibodies against bacillus anthracis protective antigen
1 ... 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 ... 1494